AIRLINK 191.54 Decreased By ▼ -21.28 (-10%)
BOP 10.23 Decreased By ▼ -0.02 (-0.2%)
CNERGY 6.69 Decreased By ▼ -0.31 (-4.43%)
FCCL 33.02 Decreased By ▼ -0.45 (-1.34%)
FFL 16.60 Decreased By ▼ -1.04 (-5.9%)
FLYNG 22.45 Increased By ▲ 0.63 (2.89%)
HUBC 126.60 Decreased By ▼ -2.51 (-1.94%)
HUMNL 13.83 Decreased By ▼ -0.03 (-0.22%)
KEL 4.79 Decreased By ▼ -0.07 (-1.44%)
KOSM 6.35 Decreased By ▼ -0.58 (-8.37%)
MLCF 42.10 Decreased By ▼ -1.53 (-3.51%)
OGDC 213.01 Increased By ▲ 0.06 (0.03%)
PACE 7.05 Decreased By ▼ -0.17 (-2.35%)
PAEL 40.30 Decreased By ▼ -0.87 (-2.11%)
PIAHCLA 16.85 Increased By ▲ 0.02 (0.12%)
PIBTL 8.25 Decreased By ▼ -0.38 (-4.4%)
POWER 8.85 Increased By ▲ 0.04 (0.45%)
PPL 182.89 Decreased By ▼ -0.14 (-0.08%)
PRL 38.10 Decreased By ▼ -1.53 (-3.86%)
PTC 23.90 Decreased By ▼ -0.83 (-3.36%)
SEARL 93.50 Decreased By ▼ -4.51 (-4.6%)
SILK 1.00 Decreased By ▼ -0.01 (-0.99%)
SSGC 39.85 Decreased By ▼ -1.88 (-4.51%)
SYM 18.44 Decreased By ▼ -0.42 (-2.23%)
TELE 8.66 Decreased By ▼ -0.34 (-3.78%)
TPLP 12.05 Decreased By ▼ -0.35 (-2.82%)
TRG 64.50 Decreased By ▼ -1.18 (-1.8%)
WAVESAPP 10.50 Decreased By ▼ -0.48 (-4.37%)
WTL 1.78 Decreased By ▼ -0.01 (-0.56%)
YOUW 3.96 Decreased By ▼ -0.07 (-1.74%)
BR100 11,697 Decreased By -168.8 (-1.42%)
BR30 35,252 Decreased By -445.3 (-1.25%)
KSE100 112,638 Decreased By -1510.2 (-1.32%)
KSE30 35,458 Decreased By -494 (-1.37%)

Multinational pharmaceutical companies would stop production of many essential life-saving drugs if the Drugs Regulatory Authority of Pakistan (DRAP) adopts its proposed pricing formula called "Average Pricing" method, instead of introducing "Reference Pricing" formula, Business Recorder learnt here on Thursday.
"Average pricing method may force the top local and multinational pharmaceutical companies to stop production of many `unfeasible' drugs as the top manufacturers do not compromise on their quality standards which are prime factors in their pricing," industry sources told this correspondent.
According to sources, there is a consensus among PPMA, Pharma Bureau and the Pakistan Chemists & Druggist Association (PCDA) to have "Reference Pricing" formula which is prevalent in countries with similar socio-economic conditions. The sources claimed although the prices of drugs, under a formula proposed by the ECC, would increase the prices by around 93 per cent, the pharmaceutical companies had agreed to increase the prices by only 15pc in the interest of patients.
They said: "Although Sindh High Court had ordered the DRA to come up with a pricing policy in consultation with all stakeholders, DRA is gearing up to come up with a `destructive' formula of average pricing. Such a move on the part of DRA would increase the prices of sub-standard drugs and compel quality drug makers to stop production and wrap up their businesses," sources feared.
They also claimed that the DRA has refused to take into account considerations of the external stakeholders. "Such a move on the part of DRA will ultimately hit consumers when most of the drugs will not be available in the market. Recent shortage of life-saving drugs and vaccines was just a trailer," the sources threatened.
The pharmaceutical industry of the country has been asking for price increase since long, but the government is bent upon introducing new formula in the new drug policy, the sources said, adding that "such a move would mean a government sponsored 'cartel' as opposed to efficient market dynamics which is the tested method of ensuring viability of the industry and at the same time allowing competitive forces to force the price down automatically," the source opined.

Copyright Business Recorder, 2014

Comments

Comments are closed.